[1]
S. Lovas, “Efficacy and Safety of Daratumumab, Lenalidomide and Dexamethasone Therapy in the First Relapse of Multiple Myeloma Patients – Real World Data from Hungary”, J Hematol, vol. 14, no. 6, pp. 314–323, Jan. 2025, doi: 10.14740/jh2142.